Answering a question that has lingered for centuries, a team of scientists has proved that chemicals used to treat the wood used in Stradivarius and Guarneri violins are the reasons for the distinct sound produced by the world-famous instruments.
The conclusions, published in the current issue of Nature magazine, have confirmed 30 years of work into the subject by Joseph Nagyvary, professor emeritus of biochemistry at Texas A&M University, who was the first to theorize that chemicals – not necessarily the wood – created the unique sound of the two violins. Nagyvary teamed with collaborators Joseph DiVerdi of Colorado State University and Noel Owen of Brigham Young University on the project.
“This research proves unquestionably that the wood of the great masters was subjected to an aggressive chemical treatment and the chemicals – most likely some sort of oxidizing agents – had a crucial role in creating the great sound of the Stradivarius and the Guarneri,” Nagyvary says.
“Like many discoveries, this one could have been accidental. Perhaps the violin makers were not even aware of the acoustical effects of the chemicals. Both Stradivari and Guarneri wanted to treat their violins to prevent worms from eating away the wood. They used some chemical agents to protect the wood from worm infestations of the time, and the unintended consequence from these chemicals was a sound like none other,” he adds.
The team tested several instruments, including violins and cellos, produced by Stradivari and Guarneri from 1717 to around 1741, using spectra analysis and other methods.
The results and those previously reported by Nagyvary showed that two specific areas of the instruments accounted for their unique sound – chemicals used in the varnish and fillers of the instruments, and the overall wood treatment process used by Stradivari and Guarneri.
“This is highly gratifying for me, because it proves what I first proposed 30 years ago – that the chemicals used to treat instruments and not the unadulterated wood itself – were the reasons for the great sound of these instruments,” Nagyvary explains.
“I was criticized and ridiculed when I made these claims, and to have undeniable scientific proof that I was correct is very satisfying, to say the least.”
Antonio Stradivari (1644 to 1737) made about 1,200 violins in his lifetime and kept a large inventory of them, and would only sell one when he was ready to part with it. Today, there are only about 600 Stradivarius violins remaining and they are valued at up to $5 million each.
Although lesser known, Guarneri del Gesu was a contemporary of Stradivari and his instruments are considered equal in quality and price by experts.
Nagyvary, a native of Hungary who learned to play the violin by using an instrument that once belonged to Albert Einstein, has wondered for years how Stradivari, who could barely read and had no scientific training, could have produced instruments with such a pristine sound.
“I started researching this in the early 1970s and from the beginning, I was convinced that the chemicals used to treat the instruments were the real key, not the wood itself,” he says.
There is still a missing piece of the puzzle, Nagyvary believes.
“The next step is to identify the chemical agents involved. To do that, more precious wood samples are needed,” he adds.
“But in the past, there has been a lack of cooperation from the antique violin business, and that has to be overcome. It may help us to produce violins and other instruments one day that are just as good as the million-dollar Stradivarius. And this research could also tell us ways to better preserve instruments, too.”
Keith Randall | EurekAlert!
New RNA sequencing strategy provides insight into microbiomes
17.12.2018 | University of Chicago Medical Center
Mass spectrometry sheds new light on thallium poisoning cold case
14.12.2018 | University of Maryland
Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.
Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
17.12.2018 | Physics and Astronomy
17.12.2018 | Architecture and Construction
17.12.2018 | Life Sciences